Synergistical Use of Electrostatic and Hydrophobic Interactions for the Synthesis of a New Class of Multifunctional Nanohybrids: Plasmonic Magneto-Liposomes
- PMID: 31731719
- PMCID: PMC6915406
- DOI: 10.3390/nano9111623
Synergistical Use of Electrostatic and Hydrophobic Interactions for the Synthesis of a New Class of Multifunctional Nanohybrids: Plasmonic Magneto-Liposomes
Abstract
By carefully controlling the electrostatic interactions between cationic liposomes, which already incorporate magnetic nanoparticles in the bilayers, and anionic gold nanoparticles, a new class of versatile multifunctional nanohybrids (plasmonic magneto-liposomes) that could have a major impact in drug delivery and controlled release applications has been synthesized. The experimental results confirmed the successful synthesis of hydrophobic superparamagnetic iron oxide nanoparticles (SPIONs) and polyethylene glycol functionalized (PEGylated) gold nanoparticles (AuNPs). The SPIONs were incorporated in the liposomal lipidic bilayers, thus promoting the formation of cationic magnetoliposomes. Different concentrations of SPIONs were loaded in the membrane. The cationic magnetoliposomes were decorated with anionic PEGylated gold nanoparticles using electrostatic interactions. The successful incorporation of SPIONs together with the modifications they generate in the bilayer were analyzed using Raman spectroscopy. The plasmonic properties of the multifunctional nanohybrids were investigated using UV-Vis absorption and (surface-enhanced) Raman spectroscopy. Their hyperthermic properties were recorded at different frequencies and magnetic field intensities. After the synthesis, the nanosystems were extensively characterized in order to properly evaluate their potential use in drug delivery applications and controlled release as a result of the interaction with an external stimulus, such as an NIR laser or alternating magnetic field.
Keywords: gold nanoparticles; hyperthermia; magneto-liposomes; multifunctional nanohybrids; superparamagnetic nanoparticles.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
A new class of pegylated plasmonic liposomes: synthesis and characterization.J Colloid Interface Sci. 2015 Jan 1;437:17-23. doi: 10.1016/j.jcis.2014.09.023. Epub 2014 Sep 21. J Colloid Interface Sci. 2015. PMID: 25310578
-
Magnetoliposomes as Potential Carriers of Doxorubicin to Tumours.Chemistry. 2016 Dec 5;22(49):17715-17724. doi: 10.1002/chem.201602809. Epub 2016 Oct 27. Chemistry. 2016. PMID: 27786376
-
Bovine Lactoferrin-Loaded Plasmonic Magnetoliposomes for Antifungal Therapeutic Applications.Pharmaceutics. 2023 Aug 19;15(8):2162. doi: 10.3390/pharmaceutics15082162. Pharmaceutics. 2023. PMID: 37631376 Free PMC article.
-
Can magneto-plasmonic nanohybrids efficiently combine photothermia with magnetic hyperthermia?Nanoscale. 2015 Dec 7;7(45):18872-7. doi: 10.1039/c5nr06168g. Epub 2015 Oct 15. Nanoscale. 2015. PMID: 26468627 Review.
-
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.Expert Opin Drug Deliv. 2014 Sep;11(9):1449-70. doi: 10.1517/17425247.2014.924501. Epub 2014 May 29. Expert Opin Drug Deliv. 2014. PMID: 24870351 Review.
Cited by
-
Solid Plasmonic Substrates for Breast Cancer Detection by Means of SERS Analysis of Blood Plasma.Nanomaterials (Basel). 2020 Jun 21;10(6):1212. doi: 10.3390/nano10061212. Nanomaterials (Basel). 2020. PMID: 32575924 Free PMC article.
-
Quantifying Cytosolic Cytochrome c Concentration Using Carbon Quantum Dots as a Powerful Method for Apoptosis Detection.Pharmaceutics. 2021 Sep 25;13(10):1556. doi: 10.3390/pharmaceutics13101556. Pharmaceutics. 2021. PMID: 34683849 Free PMC article.
-
Doxorubicin Loaded Thermosensitive Magneto-Liposomes Obtained by a Gel Hydration Technique: Characterization and In Vitro Magneto-Chemotherapeutic Effect Assessment.Pharmaceutics. 2022 Nov 18;14(11):2501. doi: 10.3390/pharmaceutics14112501. Pharmaceutics. 2022. PMID: 36432692 Free PMC article.
-
Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes-A Preliminary Study.Nanomaterials (Basel). 2022 Aug 17;12(16):2833. doi: 10.3390/nano12162833. Nanomaterials (Basel). 2022. PMID: 36014698 Free PMC article.
-
A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy.Pharmaceutics. 2021 Sep 22;13(10):1526. doi: 10.3390/pharmaceutics13101526. Pharmaceutics. 2021. PMID: 34683821 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous